Bharat Biotech’s vaccine is safe for use on humans, not to mention effective. The envisioned timeline is markedly shorter than other front-runner vaccine efforts from American and Chinese drugmakers, most of which started human clinical trials months ago and are now entering the last of three stages of testing.The bid underscores India’s urgent need for a way to halt the coronavirus, which has sickened more than 640,000 people and killed over 18,600 in the Asian nation -- the world’s fourth-largest outbreak.
In its letter, ICMR urged the trial sites to enroll volunteers by July 7.The speediness has alarmed some in the medical fraternity. “Such an accelerated development pathway has not been done EVER for any kind of vaccine, even the ones.